Tackling dengue in the era of Covid-19
Petrick@Ramesh K Periyasmy
Universiti Malaya Medical Centre, Kuala Lumpur
Dengue fever is an endemic arbovirus especially in tropical regions and with 390 million infections per year with 10,000 deaths per year.(SARS CoV-2), has infected more than 343 million worldwide, and caused more than 5 million deaths. In 2020, dengue fever and COVID-19 began to overlap, and several dengue-endemic countries, such as Singapore, Thailand, India, and Bangladesh, have already reported coinfection. The accurate diagnosis of both infections can better guide clinical management, as well as public health actions in transmission control. This situation represents a challenge in the diagnosis and treatment of both infections, given the differences in the transmission mechanisms and their management implications. It is a priority to establish a timely diagnosis of COVID-19 in areas that are also experiencing a dengue epidemic to avoid delays in proper treatment.Therefore, laboratory tests play an important role in the clinical field and public health actions to control COVID-19 transmission. Physicians should be aware of the possibility of dengue and COVID-19 coinfection in areas with overlapping outbreaks and be aware of a potentially harmful interaction between these viruses. Comparison between COVID-19 and dengue infection are important as this can have serious clinical consequences, either through failure of adequate hydration or delay in the use of anticoagulants, corticosteroids, and early mechanical ventilation.